XFRA CAPITAL ADJUSTMENT INFORMATION

Realtime	Geld	Brief	Zeit
	40,940	42,060	07:29

Realtime

Geld

Brief

Zeit

40,940

42,060

07:29

XFRA CAPITAL ADJUSTMENT INFORMATION - 29.05.2024

Das Instrument K6Q SE0003553130 WNTRESEARCH AB SK -,09 EQUITY wird ex Kapitalmassnahme gehandelt am 29.05.2024
The instrument K6Q SE0003553130 WNTRESEARCH AB SK -,09 EQUITY is traded ex capital adjustment on 29.05.2024

Das Instrument SMI BMG2133H2006 TIAN AN MEDICARE HD-,01 EQUITY wird cum Kapitalmassnahme gehandelt am 29.05.2024 und ex Kapitalmassnahme am 30.05.2024
The instrument SMI BMG2133H2006 TIAN AN MEDICARE HD-,01 EQUITY is traded cum capital adjustment on 29.05.2024 and ex capital adjustment on 30.05.2024

Das Instrument 6JU US09060U5074 BIOCARDIA INC.NEW DL-,001 EQUITY wird cum Kapitalmassnahme gehandelt am 29.05.2024 und ex Kapitalmassnahme am 30.05.2024

The instrument 6JU US09060U5074 BIOCARDIA INC.NEW DL-,001 EQUITY is traded cum capital adjustment on 29.05.2024 and ex capital adjustment on 30.05.2024

Das Instrument 6L8 US74587B1017 PULSE BIOSCIENCES DL-,001 EQUITY wird cum Kapitalmassnahme gehandelt am 29.05.2024 und ex Kapitalmassnahme am 30.05.2024
The instrument 6L8 US74587B1017 PULSE BIOSCIENCES DL-,001 EQUITY is traded cum capital adjustment on 29.05.2024 and ex capital adjustment on 30.05.2024

Das Instrument 26Q NO0010715394 ABL GROUP ASA NA NK-,10 EQUITY wird cum Kapitalmassnahme gehandelt am 29.05.2024 und ex Kapitalmassnahme am 30.05.2024
The instrument 26Q NO0010715394 ABL GROUP ASA NA NK-,10 EQUITY is traded cum capital adjustment on 29.05.2024 and ex capital adjustment on 30.05.2024

Das Instrument 1RK US45720L1070 INHIBRX INC. DL -,0001 EQUITY wird cum Kapitalmassnahme gehandelt am 29.05.2024 und ex Kapitalmassnahme am 30.05.2024
The instrument 1RK US45720L1070 INHIBRX INC. DL -,0001 EQUITY is traded cum capital adjustment on 29.05.2024 and ex capital adjustment on 30.05.2024

Das Instrument 4GP MX01UR000007 URBI DESARROLLOS URBANOS EQUITY wird cum Kapitalmassnahme gehandelt am 29.05.2024 und ex Kapitalmassnahme am 30.05.2024
The instrument 4GP MX01UR000007 URBI DESARROLLOS URBANOS EQUITY is traded cum capital adjustment on 29.05.2024 and ex capital adjustment on 30.05.2024

Das Instrument C0Q CH0198251305 COCA-COLA HBC NA.SF 6,70 EQUITY wird cum Kapitalmassnahme gehandelt am 29.05.2024 und ex Kapitalmassnahme am 30.05.2024
The instrument C0Q CH0198251305 COCA-COLA HBC NA.SF 6,70 EQUITY is traded cum capital adjustment on 29.05.2024 and ex capital adjustment on 30.05.2024

Zeit	Aktuelle Nachrichten
26.02.	Correction: ABL Group ASA - Key information relating to the proposed cash dividend
21.02.	ABL Group ASA: Invitation to presentation of Q4 2024 results
12.02.	ABL Group ASA: Acquisition of Norwegian technical resourcing consultancy
27.01.	ABL Group ASA: Share capital increase registered
21.01.	ABL Group ASA: Allocation of shares to primary insiders

Zeit

Aktuelle Nachrichten

26.02.

Correction: ABL Group ASA - Key information relating to the proposed cash dividend

21.02.

ABL Group ASA: Invitation to presentation of Q4 2024 results

12.02.

ABL Group ASA: Acquisition of Norwegian technical resourcing consultancy

27.01.

ABL Group ASA: Share capital increase registered

21.01.

ABL Group ASA: Allocation of shares to primary insiders

Zeit	Aktuelle Nachrichten
11.03.	BCDA makes headway in ROW acquisition for railway project
10.03.	BCDA inks deal with over 95% of Camp John Hay homeowners
10.03.	BioCardia sichert sich neues japanisches Patent für Herztherapie-Verabreichung
10.03.	BioCardia, Inc.: BioCardia Announces Japanese Patent for Helix Biotherapeutic Delivery System	SUNNYVALE, Calif., March 10, 2025 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases... ► Artikel lesen
10.03.	BioCardia, Inc. - 8-K, Current Report

Zeit

Aktuelle Nachrichten

11.03.

BCDA makes headway in ROW acquisition for railway project

10.03.

BCDA inks deal with over 95% of Camp John Hay homeowners

10.03.

BioCardia sichert sich neues japanisches Patent für Herztherapie-Verabreichung

10.03.

BioCardia, Inc.: BioCardia Announces Japanese Patent for Helix Biotherapeutic Delivery System

SUNNYVALE, Calif., March 10, 2025 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases...
► Artikel lesen

10.03.

BioCardia, Inc. - 8-K, Current Report

Zeit	Aktuelle Nachrichten
Fr	COCA-COLA HBC A.G.: 2024 Annual Financial Report
Fr	Coca-Cola HBC veröffentlicht integrierten Jahresbericht 2024
Do	COCA-COLA HBC A.G.: Notification of transactions by Persons Discharging Managerial Responsibilities
11.03.	COCA-COLA HBC A.G.: Director Declaration
11.03.	Coca-Cola HBC announces board member's new director role

Zeit

Aktuelle Nachrichten

COCA-COLA HBC A.G.: 2024 Annual Financial Report

Coca-Cola HBC veröffentlicht integrierten Jahresbericht 2024

COCA-COLA HBC A.G.: Notification of transactions by Persons Discharging Managerial Responsibilities

11.03.

COCA-COLA HBC A.G.: Director Declaration

11.03.

Coca-Cola HBC announces board member's new director role

Zeit	Aktuelle Nachrichten
27.02.	PULSE BIOSCIENCES, INC. - S-8, Securities to be offered to employees in employee benefit plans
20.02.	Pulse Biosciences (NASDAQ:PLSE) Shares Down 7.8% - Here's Why
04.02.	Pulse Biosciences has a new CFO
04.02.	Pulse Biosciences Appoints Jon Skinner As CFO; Stock Up In Pre-market
04.02.	Pulse Biosciences names Jon Skinner as new CFO

Zeit

Aktuelle Nachrichten

27.02.

PULSE BIOSCIENCES, INC. - S-8, Securities to be offered to employees in employee benefit plans

20.02.

Pulse Biosciences (NASDAQ:PLSE) Shares Down 7.8% - Here's Why

04.02.

Pulse Biosciences has a new CFO

04.02.

Pulse Biosciences Appoints Jon Skinner As CFO; Stock Up In Pre-market

04.02.

Pulse Biosciences names Jon Skinner as new CFO

Zeit	Aktuelle Nachrichten
Fr	TIANAN MEDICARE (00383): (REVISED) NEXT DAY DISCLOSURE RETURN
Do	TIANAN MEDICARE (00383): NEXT DAY DISCLOSURE RETURN
11.03.	TIANAN MEDICARE (00383): FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2024
11.03.	TIANAN MEDICARE (00383): ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2024
03.03.	TIANAN MEDICARE (00383): POSITIVE PROFIT ALERT

Zeit

Aktuelle Nachrichten

TIANAN MEDICARE (00383): (REVISED) NEXT DAY DISCLOSURE RETURN

TIANAN MEDICARE (00383): NEXT DAY DISCLOSURE RETURN

11.03.

TIANAN MEDICARE (00383): FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2024

11.03.

TIANAN MEDICARE (00383): ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2024

03.03.

TIANAN MEDICARE (00383): POSITIVE PROFIT ALERT

Zeit	Aktuelle Nachrichten
28.11.24	XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 28.11.2024	The following instruments on Boerse Frankfurt do have their last trading day on 28.11.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 28.11.2024ISIN NameCA38210L1094 GOOD... ► Artikel lesen
28.11.24	XFRA 4GP: AUSSETZUNG/SUSPENSION	DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILURBI DESARROLLOS... ► Artikel lesen
29.05.24	XFRA CAPITAL ADJUSTMENT INFORMATION - 29.05.2024	Das Instrument K6Q SE0003553130 WNTRESEARCH AB SK -,09 EQUITY wird ex Kapitalmassnahme gehandelt am 29.05.2024 The instrument K6Q SE0003553130 WNTRESEARCH AB SK -,09 EQUITY is traded ex capital adjustment... ► Artikel lesen

Zeit

Aktuelle Nachrichten

28.11.24

XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 28.11.2024

The following instruments on Boerse Frankfurt do have their last trading day on 28.11.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 28.11.2024ISIN NameCA38210L1094 GOOD...
► Artikel lesen

28.11.24

XFRA 4GP: AUSSETZUNG/SUSPENSION

DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILURBI DESARROLLOS...
► Artikel lesen

29.05.24

XFRA CAPITAL ADJUSTMENT INFORMATION - 29.05.2024

Zeit	Aktuelle Nachrichten
04.02.	WntResearch CEO comments on reverse acquisition
12.11.24	Spotlight Stock Market: Market Notice 232/24- Last day of trading in WntResearch AB's subscription option WNT TO 7
17.10.24	WntResearch updates after stopped study
09.10.24	Spotlight Stock Market: Market notice 196/24 - WntResearch AB's share WNT is moved to the Observation List
09.10.24	WntResearch provides an update on the work in progress to safeguard the interests of shareholders and company values

Zeit

Aktuelle Nachrichten

04.02.

WntResearch CEO comments on reverse acquisition

12.11.24

Spotlight Stock Market: Market Notice 232/24- Last day of trading in WntResearch AB's subscription option WNT TO 7

17.10.24

WntResearch updates after stopped study

09.10.24

Spotlight Stock Market: Market notice 196/24 - WntResearch AB's share WNT is moved to the Observation List

09.10.24

WntResearch provides an update on the work in progress to safeguard the interests of shareholders and company values

Unternehmen / Aktien	Kurs	%
ABL GROUP ASA	0,786	0,00 %
BIOCARDIA INC	2,620	0,00 %
COCA-COLA HBC AG	40,520	+0,20 %
PULSE BIOSCIENCES INC	15,200	-0,65 %
TIAN AN MEDICARE LTD	0,081	+1,25 %
URBI DESARROLLOS URBANOS SAB DE CV	4,920	0,00 %
WNTRESEARCH AB	1,075	0,00 %

Unternehmen / Aktien

Kurs

ABL GROUP ASA

0,786

0,00 %

BIOCARDIA INC

2,620

0,00 %

COCA-COLA HBC AG

40,520

+0,20 %

PULSE BIOSCIENCES INC